Nabla pricing

About

Nabla makes an ambient AI clinical assistant (a “medical scribe”) that listens to the clinician–patient conversation and turns it into a structured clinical note — drafting the documentation, surfacing real-time intelligence, and pushing it into the EHR so clinicians can stop typing during visits. As of its July 2026 site refresh, Nabla organizes the product into three named lines — Ambient Documentation, Dictation, and Coding (E/M and ICD-10 coding suggestions grounded in the note and AMA guidelines) — and positions itself as “The Clinical AI Layer” embedded across care delivery, rather than a single standalone scribe app. It runs as a web app, iOS and Android apps, and a Chrome extension, and the company reports it is used by 85,000+ clinicians across 150+ health organizations, citing that 55% of clinicians save at least an hour/day on documentation, ~1.5x more patients seen per month, and a ~27% reduction in burnout among users.

Nabla was founded in Paris in 2018 by Alexandre Lebrun and Martin Raison (both ex-Facebook AI Research / Wit.ai) and Delphine Groll. Its first product was a consumer “super app for women” — practitioner chat, community content, record centralization and telemedicine, monetized via in-app purchases. In March 2023 it pivoted to Copilot, a GPT-3-powered ambient scribe for clinicians; the “Copilot” name has since receded from the public marketing site in favor of the unified “Nabla” brand, though the clinician app itself still runs at copilot.nabla.com. Nabla has raised about $120M total, including a $24M Series B in January 2024 (led by Cathay Innovation, ~$180M valuation) and a $70M round in June 2025 (led by HV Capital) as the ambient-scribe market heated up against rivals like Abridge, Ambience and Microsoft/Nuance DAX. In July 2026, Nabla named Brian Manning as CEO to lead its next growth phase, while co-founder Alexandre Lebrun continues frontier AI research through AMI Labs (with Yann LeCun) on “world models” for healthcare. Nabla also now foregrounds Nabla Connect and the Nabla Core API — an embed/API-first route for telehealth platforms and EHR vendors to build on its transcription, note-generation and FHIR-data-extraction tools — alongside partnerships like the Coalition for Health AI (CHAI) and named compliance certifications (HIPAA, SOC 2 Type II, ISO 27001, GDPR).

For the most current information, visit Nabla.

Pricing summary : How Nabla’s pricing model works

Nabla Copilot is sold per clinician (per seat) — you pay per provider, not per token, per minute, or per API call. There are three tiers. A free individual tier (reported at up to ~30 notes/consultations per month, with unlimited notes for residents and interns) is reachable through a self-serve “Try it for free” signup on the homepage. A paid Pro plan — reported at roughly $119/month per provider — lifts the cap to unlimited notes and adds full EHR integration for individual clinicians and small practices. Enterprise is a quoted annual contract for hospitals and telehealth companies, adding SAML SSO, custom/tailored models, custom integrations and dedicated support.

The important caveat: Nabla does not publish a price list. Its /pricing URL still returns a 404 (re-confirmed 2026-07-30), and the site routes you to either “Try it for free” or “Talk to our team.” So while the per-clinician structure is clear, the $119/mo Pro figure is third-party-reported (consistently, across several review aggregators) rather than an official Nabla rate, and the free-tier note cap is likewise reported, not posted.

There is now a fourth, sales-led route alongside the three clinician tiers: Nabla Connect / Nabla Core API, aimed at telehealth platforms, EHR vendors and health-tech builders who want to embed Nabla’s transcription, note-generation and FHIR-data-extraction capabilities into their own product rather than have their clinicians use the Nabla app directly. Like Enterprise, this track has no public pricing — it is quote-only via “Talk to our team,” and the API itself (documented at docs.nabla.com) shows technical capabilities and versioning but no rate card or usage-based pricing figures.

What makes this different: in a category where almost every enterprise healthcare-AI scribe is demo-and-quote only, Nabla keeps a genuinely free, self-serve clinician tier — and even gives residents and interns unlimited notes. That is a deliberate bottom-up, land-and-expand wedge: get individual clinicians (and the next generation of doctors) hooked for free, then convert seats and sell the hospital an Enterprise contract — while a separate, sales-led API/embed track monetizes platform partners who want the AI without the clinician-facing app.

Pricing by product

Sales motions across products: self-serve PLG for the Free and (reported) Pro tiers — sign up, scribe your visits, pay per provider — and sales-led for Enterprise (hospital/telehealth deployments with SSO, custom models and a dedicated team) and for Nabla Connect/Core API (platform partners embedding Nabla’s AI). The free residents/interns allowance is the top of a bottom-up funnel into paid seats and enterprise contracts; the API track is a separate, quote-only funnel for partners, not clinicians.

Hidden costs : What Nabla users actually pay

Because Nabla is a flat per-seat subscription (not consumption-based), there are no token, minute, or overage meters to blow up your bill — the main “hidden” cost is which tier each clinician actually needs. The free tier’s ~30-note/month cap is the gate: any working clinician seeing a normal patient panel will exhaust it within days and effectively needs the unlimited Pro seat. The residents/interns carve-out is the exception that stays free.

Other things to budget for: the published $119 is unconfirmed — because Nabla quotes paid tiers privately, real per-seat pricing can vary by volume and may be negotiated down at the group/hospital level, so individual sticker price and an enterprise per-seat rate are different conversations. EHR integration is included (not an add-on) on Pro, which removes a common healthcare-IT surcharge. SSO and custom models are Enterprise-only, so security/compliance requirements push you out of the self-serve tiers and into a sales cycle.

Want to estimate your own Nabla bill? Use the Nabla pricing calculator to model your costs based on seat counts.

Pricing evolution : Nabla pricing history and changes

Cadence

Tracked range: 2018–present. Nabla publishes no price page (the /pricing URL 404s) and historical Wayback renders of pricing are essentially absent, so the timeline anchors on the 2023 Copilot launch, the live 2026-06-10 homepage capture, and consistent third-party pricing reports for the paid tiers.

Notable changes

• 2021-04 — Nabla operates as a consumer “super app for women” (practitioner chat, telemedicine, in-app purchases) — a different product and pricing model from today’s scribe.
• 2023-03 — Pivot to Nabla Copilot, a GPT-3 ambient scribe, launched free to clinicians to drive bottom-up adoption — establishing the per-clinician (not per-token) model.
• 2024–2026 — A paid Pro tier (reported ~$119/mo per provider, unlimited notes + EHR) and a quoted Enterprise tier (SAML SSO, custom models) layer on top of the retained free tier; Nabla keeps the price list off its website.

What’s unique : Nabla’s distinctive pricing mechanics

1. A genuinely free, self-serve clinician tier in enterprise health AI. Most ambient scribes (Abridge, Ambience, Nuance DAX) are demo-and-quote only. Nabla keeps a real “Try it for free” signup with a free monthly note allowance — a self-serve wedge into a category that is otherwise entirely sales-led.

2. Unlimited free notes for residents and interns. Rather than just a trial, Nabla gives trainees unlimited notes for free. That seeds the product inside teaching hospitals and habituates the next generation of physicians before anyone signs a contract — a long-horizon, bottom-up land-and-expand mechanic.

3. Per-clinician, not per-token. Despite being an LLM-heavy product, Nabla bills by the clinician seat, not by tokens, minutes, or notes (above the free cap). That makes a paid clinician’s cost completely predictable — a deliberate contrast to consumption-metered AI infra, and a better fit for how hospitals budget headcount.

Strengths & weaknesses

Billing UX : Nabla billing controls and transparency

• Billing controls — Self-serve signup for the free tier (and, where reported, Pro) means a clinician can onboard without a sales call; Enterprise moves to an invoiced annual contract with a dedicated team. Because pricing is per seat, the main “control” is how many provider seats you license.
• Usage visibility — The free tier’s ~30-note/month allowance is the one place usage matters; above that, Pro is flat unlimited, so there is little ongoing usage to monitor. The product surfaces documentation-time-saved metrics to clinicians, which doubles as adoption (not billing) visibility.
• Payment options — Self-serve card billing for individual paid seats (as reported); Enterprise is invoiced under a custom annual contract. Nabla does not publish billing terms publicly, so group/hospital invoicing details are quote-stage.
• API/partner billing — docs.nabla.com documents the Nabla Core API’s capabilities, authentication, webhooks, and versioning in detail, but publishes no rate card or usage-metering unit — partners must go through “Talk to our team” to get a quote, so there is no self-serve API pricing control.

Strategic wins : Why Nabla’s pricing decisions worked

1. Free clinician entry in a sales-led category

By offering a real free tier and a self-serve signup, Nabla bypassed the slow hospital procurement cycle and let individual clinicians adopt directly — a bottom-up motion that helped it reach 85,000+ clinicians while rivals relied on top-down enterprise sales. See how AI companies structure pricing.

2. Per-seat, not per-token, predictability

Pricing the LLM product per clinician (not per token or minute) makes a paid seat’s cost flat and predictable — which matches how hospitals budget staff and removes the bill-shock risk that plagues consumption-metered AI. Related: choosing the right usage metric.

3. Land on trainees, expand to the hospital

Free unlimited notes for residents and interns plant Nabla inside teaching hospitals and habituate future attendings — turning a pricing concession into a multi-year expansion funnel. See outcome-based pricing trends.

Areas to improve : Gaps in Nabla’s pricing approach

1. No public price list

The paid tiers live entirely off-site (the /pricing URL 404s), so buyers rely on third-party reports for the ~$119/mo figure. Publishing even a Pro list price would shorten self-qualification and reduce the trust gap. See bill shock and cost unpredictability.

2. The free cap is a cliff

A ~30-note/month free allowance is exhausted within days by any working clinician, so the free tier functions as a short trial rather than a durable plan. A clearer “this is a trial, not a tier” framing — or a higher cap — would set expectations better.

3. Compliance gated to Enterprise

SSO and custom models are Enterprise-only, so any clinic with security requirements is pushed into a quote-only sales cycle with no published per-seat economics — slowing mid-market self-qualification.

Key takeaways

1. A free, self-serve tier can break into a sales-led category. Nabla used free clinician access to reach 85,000+ users while ambient-scribe rivals stayed demo-and-quote.
2. Bill per seat, not per token, for predictability. Pricing an LLM product per clinician makes cost flat and budgetable — a deliberate contrast to consumption metering.
3. Free for trainees is a land-and-expand wedge. Unlimited notes for residents/interns seed teaching hospitals and the next generation of buyers.
4. Off-site pricing is a double-edged sword. Keeping no public list preserves enterprise negotiating room but forces buyers onto third-party-reported figures (~$119/mo) and erodes transparency.
5. Healthcare AI is settling on per-clinician seats. Nabla’s structure signals per-provider subscription — not per-token usage — as the emerging default for ambient scribes.

UBP implications

1. Per-seat is a defensible value metric when usage is uniform. A clinician documents a roughly bounded number of visits, so a flat per-provider seat captures value without the forecasting pain of consumption metering. See usage-based pricing strategy.
2. A capped free tier is a usage meter in disguise. Nabla’s ~30-note/month free allowance is a soft consumption gate that qualifies real users into paid seats — a UBP mechanic dressed as a freemium plan.
3. Bottom-up free access compounds in regulated markets. Giving trainees free unlimited usage is a long-horizon acquisition investment that pays off as they become paying attendings — relevant for anyone monetizing inside slow enterprise/regulated buyers.

Sources

• Nabla official website (accessed 2026-07-30) — live homepage capture; rebrand to “Nabla — The Clinical AI Layer”, Ambient Documentation/Dictation/Coding product lines, Nabla Connect
• Nabla Core API docs (accessed 2026-07-30) — API capabilities, versioning (2026-07-01), no published rate card
• Nabla Copilot free-signup flow (accessed 2026-07-30) — unchanged self-serve email signup, no pricing shown
• Meet Brian Manning, CEO of Nabla — Nabla blog (accessed 2026-07-30) — CEO appointment (published ~2026-07-22); three product lines (Ambient AI, Dictation, Coding); co-founder Alexandre Lebrun’s continued AI research via AMI Labs
• Nabla Copilot pricing & plans — SaaSworthy (accessed 2026-06-10) — Free 30/mo, Pro $119/mo, Enterprise custom
• Nabla AI pricing — eesel AI (accessed 2026-06-10) — Free $0 up to 30 consults; Pro $119/mo unlimited; Enterprise SAML SSO
• Nabla — Reviews, Features, Pricing — revoyant (accessed 2026-06-10) — Freemium, starts at $119/month
• Nabla launches Copilot using GPT-3 — TechCrunch (accessed 2026-06-10)
• Nabla is building a healthcare super app for women — TechCrunch (accessed 2026-06-10)
• Nabla raises $24M Series B — PR Newswire (accessed 2026-06-10)
• Nabla raises $70 million as ambient scribe market heats up — STAT (accessed 2026-06-10)

Bottom line

Nabla Copilot is an ambient AI clinical scribe sold per clinician — and it stands out in a demo-and-quote category by keeping a genuinely free, self-serve tier (reported ~30 notes/month, unlimited for residents and interns). Its paid Pro plan is reported at roughly $119/month per provider for unlimited notes plus EHR integration, and Enterprise is a quoted contract adding SAML SSO and custom models — but Nabla publishes no price list (the /pricing URL 404s), so the paid figures are third-party-reported rather than official. The per-seat (not per-token) structure makes a paid clinician’s cost fully predictable, while free unlimited notes for trainees seed teaching hospitals as a long-horizon land-and-expand funnel. Browse the pricing blueprint for more fully-researched company profiles.

Want to compare Nabla against other healthcare and vertical-AI companies? Browse the pricing blueprint.

Pricing timeline : Major events on a vertical axis

Each milestone below corresponds to a public pricing change, product launch, or material adjustment. Major events use a filled marker; minor adjustments use a faded one.

Rebrands to 'Nabla — The Clinical AI Layer'; Brian Manning named CEO

Jul 2026

Nabla dropped the standalone 'Copilot' product name for a unified 'Nabla' platform brand, formalized three named product lines (Ambient Documentation, Dictation, Coding), and named Brian Manning CEO. It also foregrounded 'Nabla Connect' (embed) and the 'Nabla Core API' as a build-on-us route for telehealth/EHR partners. No pricing was published for any of this — the /pricing URL still 404s and the free/paid/enterprise structure for clinicians is unchanged and still gated.

Free tier + reported ~$119/mo Pro + quoted Enterprise

Jun 2026

Current shape: a free individual tier (reported ~30 notes/mo, unlimited for residents/interns), a paid Pro reported at ~$119/mo per provider (unlimited notes, full EHR integration), and a quoted Enterprise (SAML SSO, custom models, dedicated support). Nabla publishes no price list — the /pricing URL 404s and the homepage routes to 'Try it for free' or 'Talk to our team'.

Launches Nabla Copilot (GPT-3 ambient scribe), free for clinicians

Mar 2023

Nabla pivoted to Copilot, a GPT-3-powered ambient AI assistant that turns the patient conversation into clinical notes. It launched free to clinicians to drive bottom-up adoption, establishing the per-clinician (not per-token) model and the free self-serve entry point.

Women's health 'super app' (pre-scribe)

Apr 2021

Nabla's first product was a consumer healthcare 'super app' for women — practitioner chat, community content, medical-record centralization and telemedicine — monetized via in-app purchases/subscriptions, not a clinician scribe. This is the pre-pivot Nabla; pricing here is irrelevant to the current Copilot product.